Back

Clinical red flags associated with transthyretin amyloid cardiomyopathy in patients with left ventricular hypertrophy: results of the TTRACK study

28 August 2023 (09:50 - 10:00)
Organised by: Logo
Congress Presentation Part of: Heart failure phenotypes and outcomes Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Thibaud Damy

University Hospital Henri Mondor, Creteil (France)

5 More presentations in this session

Presentation thumbnail
Epidemiology of acute heart failure admissions in Iceland: phenotype distribution and prognostic implications.
Doctor I. Ingimarsdottir (Reykjavik, IS)
Abstract Slides Video
Presentation thumbnail
Contrasting patterns of symptoms compared to mortality in women and men with Congestive Heart Failure (the G-CHF registry)
Doctor M. Walli-Attaei (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Cause-specific death in heart failure across the ejection fraction spectrum
Doctor C. Settergren (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Relationship between change in Kansas City Cardiomyopathy Questionnaire scores and outcomes in patients with HFrEF
Doctor M. Yang (Nanjing, CN)
Abstract Slides Video
Presentation thumbnail
Outcomes of asymptomatic left ventricular dysfunction in the patient with or without type 2 diabetic Mellitus
Doctor L. Ling (Taipei, TW)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure phenotypes and outcomes
Video

The Event

Event poster

ESC Congress 2023

28 August 2023 09:50 CET
You may be interested in
thumbnail
Congress Presentation
Prevalence and characteristics of transthyretin amyloid cardiomyopathy in patients with left ventricular hypertrophy: final analysis of the TTRACK study
thumbnail
Congress Presentation
Age- and sex-related trends in transthyretin amyloid cardiomyopathy prevalence in older patients with unexplained hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Transthyretin amyloid cardiomyopathy among patients with hypertrophic cardiomyopathy: clinical, cardiac imaging, and electrocardiographic findings from the TTRACK study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources